Company profile

Ticker
VXRT
Exchange
Website
CEO
Wouter W. Latour
Employees
Incorporated in
Location
Fiscal year end
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., Nabi Biopharmaceuticals, Nabi, Nabi Biopharmaceuticals, North American Biologicals Inc
SEC CIK
IRS number
591212264

VXRT stock data

(
)
FINRA relative short interest over last month (20 trading days) ?

Calendar

19 Mar 20
30 Mar 20
31 Dec 20

News

Company financial data Financial data

Quarter (USD) Dec 19 Sep 19 Jun 19 Mar 19
Revenue 3.92M 454K 85K 5.41M
Net income -6.41M -5.26M -5.64M -1.34M
Diluted EPS -0.13 -0.32 -0.39 -0.18
Net profit margin -164% -1159% -6632% -24.76%
Operating income -5.63M -4.71M -5M -448K
Net change in cash -6.03M 3.3M 7.88M -3.08M
Cash on hand 13.51M 19.54M 16.24M 8.36M
Cost of revenue
Annual (USD) Dec 19 Dec 18 Dec 17
Revenue 9.86M 4.16M 5.84M
Net income -18.65M -18.01M -9.58M
Diluted EPS -0.86 -2.9 -91.65
Net profit margin -189% -433% -164%
Operating income -15.79M -21.76M -10.02M
Net change in cash 2.07M 9.87M
Cash on hand 13.51M 11.44M 1.57M
Cost of revenue

Financial data from Vaxart earnings reports

Date Owner Security Transaction Code $Price #Shares $Value #Remaining
18 Nov 19 Robert A. Yedid Stock Option Common Stock Grant Aquire A 0.31 54,720 16.96K 54,720
18 Nov 19 Todd C Davis Stock Option Common Stock Grant Aquire A 0.31 54,720 16.96K 54,720
7 Nov 19 Armistice Capital Common Stock Buy Aquire P 0 0 0 25,200,000
7 Nov 19 Armistice Capital Common Stock Buy Aquire P 0.34 63,749 21.67K 25,200,000
6 Nov 19 Armistice Capital Common Stock Buy Aquire P 0 0 0 25,136,251
6 Nov 19 Armistice Capital Common Stock Buy Aquire P 0.34 61,869 21.04K 25,136,251
5 Nov 19 Armistice Capital Common Stock Buy Aquire P 0 0 0 25,074,382
5 Nov 19 Armistice Capital Common Stock Buy Aquire P 0.33 74,382 24.55K 25,074,382
37.9% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 20 20
Opened positions 3 5 -40.0%
Closed positions 3 4 -25.0%
Increased positions 4 3 +33.3%
Reduced positions 2 3 -33.3%
13F shares
Current Prev Q Change
Total value 12.91M 13.12M -1.6%
Total shares 26.82M 26.56M +1.0%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Armistice Capital 25.2M $8.83M +5.0%
Renaissance Technologies 1.37M $480K +41.8%
UBS UBS 62.72K $22K -41.7%
Geode Capital Management 44.73K $15K 0.0%
BLK BlackRock 40.41K $15K 0.0%
Vanguard 33.22K $12K 0.0%
Carlson Capital Management 28.45K $10K 0.0%
DB Deutsche Bank 10.84K $3K NEW
Parallel Advisors 10.4K $4K +50.7%
RPg Family Wealth Advisory 10K $3.51M 0.0%
Largest transactions
Shares Bought/sold Change
Armistice Capital 25.2M +1.2M +5.0%
Sabby Management 0 -1.2M EXIT
Renaissance Technologies 1.37M +403.82K +41.8%
Citadel Advisors 0 -86.22K EXIT
UBS UBS 62.72K -44.88K -41.7%
VIRT Virtu Financial 0 -27.97K EXIT
DB Deutsche Bank 10.84K +10.84K NEW
Victory Capital Management 7.95K +5.78K +267.1%
Parallel Advisors 10.4K +3.5K +50.7%
IFP Advisors 0 -162 EXIT
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: accredited, aerosolized, ahead, Armistice, arose, bear, borne, broker, campaign, ceiling, China, coincide, compliment, Concept, confront, disappointing, divest, dot, downturn, elder, encompassing, endeavor, Equine, estate, expiry, fourfold, Fundamental, grace, Gravidarum, HBGA, hedge, immunogenecity, ImmunoTech, implicit, incorrectly, incurrence, intensified, IRS, Janssen, malaise, marginal, Master, Moderna, mortgage, Myalgia, nonroutine, orange, OUM, partnership, penny, permanent, placement, PP, Proof, purple, ready, repaid, residence, revert, RIAA, robert, rolling, RPO, runway, sentinel, shareholder, speculative, spread, stepdown, surpassed, tabulated, TEAE, todd, topline, Trump, unbilled, underwritten, unexercised, unpartnered, Venezuelan, worth, wrote, Wuhan, yedid
Removed: accelerated, acquirer, amendment, American, August, AVIR, award, Biota, calculating, capsid, Carlo, chemical, circumvented, Colonnese, compensatory, comprised, compulsory, condyloma, consisted, continuation, cox, denied, description, disposition, disseminate, Dunne, expiring, function, fusion, geoffrey, GLP, incorporation, Joseph, Mark, mature, meal, Monte, nabi, NI, Patti, preceding, principle, prospectively, reject, remeasurement, restated, richard, Russell, SA, salary, scaling, simulation, sponsored, street, sum, taxable, upper, vapendavir, vice, website, withdrawn